These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26516172)

  • 1. Improved outcome with repeated intracoronary injection of bone marrow-derived cells within a registry: rationale for the randomized outcome trial REPEAT.
    Assmus B; Alakmeh S; De Rosa S; Bönig H; Hermann E; Levy WC; Dimmeler S; Zeiher AM
    Eur Heart J; 2016 Jun; 37(21):1659-66. PubMed ID: 26516172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
    Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
    Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minute Myocardial Injury as Measured by High-Sensitive Troponin T Serum Levels Predicts the Response to Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells in Patients With Stable Chronic Post-Infarction Heart Failure: Insights From the TOPCARE-CHD Registry.
    Luu B; Leistner DM; Herrmann E; Seeger FH; Honold J; Fichtlscherer S; Zeiher AM; Assmus B
    Circ Res; 2017 Jun; 120(12):1938-1946. PubMed ID: 28351842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR Study.
    Gyöngyösi M; Giurgea GA; Syeda B; Charwat S; Marzluf B; Mascherbauer J; Jakab A; Zimba A; Sárközy M; Pavo N; Sochor H; Graf S; Lang I; Maurer G; Bergler-Klein J;
    PLoS One; 2016; 11(10):e0164908. PubMed ID: 27764157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained improvement in left ventricular function after bone marrow derived cell therapy in patients with acute ST elevation myocardial infarction. A 5-year follow-up from the Stem Cell Transplantation in Ischaemic Myocardium Study.
    Moccetti T; Sürder D; Klersy C; Vassalli G; Crljenica C; Rossi MG; Pasotti E; Soldati G
    Swiss Med Wkly; 2012; 142():w13632. PubMed ID: 22833405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
    Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial.
    Mathur A; Fernández-Avilés F; Bartunek J; Belmans A; Crea F; Dowlut S; Galiñanes M; Good MC; Hartikainen J; Hauskeller C; Janssens S; Kala P; Kastrup J; Martin J; Menasché P; Sanz-Ruiz R; Ylä-Herttuala S; Zeiher A;
    Eur Heart J; 2020 Oct; 41(38):3702-3710. PubMed ID: 32860406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial.
    Mathur A; Arnold R; Assmus B; Bartunek J; Belmans A; Bönig H; Crea F; Dimmeler S; Dowlut S; Fernández-Avilés F; Galiñanes M; Garcia-Dorado D; Hartikainen J; Hill J; Hogardt-Noll A; Homsy C; Janssens S; Kala P; Kastrup J; Martin J; Menasche P; Miklik R; Mozid A; San Román JA; Sanz-Ruiz R; Tendera M; Wojakowski W; Ylä-Herttuala S; Zeiher A
    Eur J Heart Fail; 2017 Nov; 19(11):1545-1550. PubMed ID: 28948706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
    Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
    Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.
    Assmus B; Walter DH; Seeger FH; Leistner DM; Steiner J; Ziegler I; Lutz A; Khaled W; Klotsche J; Tonn T; Dimmeler S; Zeiher AM
    JAMA; 2013 Apr; 309(15):1622-31. PubMed ID: 23592107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of myocardial viability with 201Tl/18F-FDG DISA-SPECT technique in patients with acute myocardial infarction after emergent intracoronary autologous bone marrow mononuclear cells transplantation].
    Huang RC; Yao K; Qian JY; Niu YH; Ge L; Chen SG; Shi HC; Zhang YQ; Sun AJ; Wang KQ; Zou YZ; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):500-3. PubMed ID: 17711705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observation on the safety: clinical trail on intracoronary autologous bone marrow mononuclear cells transplantation for acute myocardial infarction].
    Yao K; Huang RC; Ge L; Qian JY; Li YL; Xu SK; Zhang F; Zhang YQ; Niu YH; Shi JH; Zhang SH; Fan B; Wang QB; Sun AJ; Zou YZ; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):577-81. PubMed ID: 17081355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical Results.
    Sürder D; Manka R; Moccetti T; Lo Cicero V; Emmert MY; Klersy C; Soncin S; Turchetto L; Radrizzani M; Zuber M; Windecker S; Moschovitis A; Bühler I; Kozerke S; Erne P; Lüscher TF; Corti R
    Circ Res; 2016 Jul; 119(3):481-90. PubMed ID: 27267068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.
    Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Hölschermann H; Yu J; Corti R; Mathey DG; Hamm CW; Süselbeck T; Werner N; Haase J; Neuzner J; Germing A; Mark B; Assmus B; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2006 Dec; 27(23):2775-83. PubMed ID: 17098754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
    Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design.
    Raval AN; Cook TD; Duckers HJ; Johnston PV; Traverse JH; Abraham WT; Altman PA; Pepine CJ
    Am Heart J; 2018 Jul; 201():141-148. PubMed ID: 29803986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary bone marrow cell application for terminal heart failure in children.
    Rupp S; Jux C; Bönig H; Bauer J; Tonn T; Seifried E; Dimmeler S; Zeiher AM; Schranz D
    Cardiol Young; 2012 Oct; 22(5):558-63. PubMed ID: 22329889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.